Fibroadenoma in adolescent females after living donor liver transplantation

Tanaka, N.; Ueno, T.; Takama, Y.; Yamanaka, H.; Tazuke, Y.; Bessho, K.; Okuyama, H.

doi:https://doi.org/10.1111/petr.12947

Fibroadenoma in adolescent females after living donor liver transplantation

Tanaka, N.; Ueno, T.; Takama, Y. et al.

Pediatric Transplantation, 2017, 21(6), e12947

Number of Access:976（2025-07-22 22:01 Counts）

Identifier to cite or link to this item: https://hdl.handle.net/11094/99836

Link to primary information

File	Format	Terms of use	Size	Views	Date.Available	Description	information
PediatrTransplant_21_6_e12947	pdf	None	247 KB	462	2025.01.23

Item Information

Output File Export EndNote Basic Export Mendeley

Title	Fibroadenoma in adolescent females after living donor liver transplantation
Creator	NRID 1000020456958 1000020456958 CreatorName Tanaka, N.
	NRID 1000010456957 1000010456957 ORCID 0000-0002-4639-8814 0000-0002-4639-8814 researchmap permalink ueno-pedsurg ueno-pedsurg Scopus Author ID 21743992300 21743992300 CreatorName Ueno, T.
	NRID 1000050467560 1000050467560 researchmap permalink tytyty_ytytyt tytyty_ytytyt CreatorName Takama, Y.
	NRID 1000070467570 1000070467570 CreatorName Yamanaka, H.
	NRID 1000010397698 1000010397698 researchmap permalink yukotazuke-osaka yukotazuke-osaka Scopus Author ID 7006109798 7006109798 ORCID 0000-0002-8335-0414 0000-0002-8335-0414 CreatorName Tazuke, Y.
	NRID 1000080423169 1000080423169 researchmap permalink KazuBe KazuBe CreatorName Bessho, K.
	NRID 1000030252670 1000030252670 researchmap permalink okuyamahiroomi okuyamahiroomi Scopus Author ID 35496082300 35496082300 ORCID 0000-0002-1347-282X 0000-0002-1347-282X CreatorName Okuyama, H.
Subject	adolescent female
	cyclosporine
	fibroadenoma
	living donor liver transplantation
Description	This is the peer reviewed version of the following article: Tanaka N., Ueno T., Takama Y., et al. Fibroadenoma in adolescent females after living donor liver transplantation. Pediatric Transplantation 21, e12947 (2017), which has been published in final form at https://doi.org/10.1111/petr.12947. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages thereof by third parties from platforms, services and websites other than Wiley Online Library must be prohibited.
Abstract	Breast FA is the most common breast tumor diagnosed in young women. Female renal transplant recipients on CsA have an increased risk of developing FA. However, reports of FA after LDLT have not been described. Our objectives were to determine the incidence of FA, analyze risk factors for FA, and evaluate treatment strategies in adolescent females after LDLT. A total of 18 female patients aged 10-19 years who underwent LDLT and survived at least one year after transplantation were enrolled in our study. The incidence of FA was 11.1%. To determine pre- or post-transplant conditions that are associated with FA after transplantation, the patients were divided into two groups according to the presence or absence of FA: FA group (n=2) and non-FA group (n=16). There were no differences in mean age at LDLT, mean age at breast evaluation, and mean duration between transplantation and breast evaluation between the two groups. However, there was a difference in the immunosuppressive regimen between the two groups. The FA group was maintained on CsA, whereas the non-FA group was maintained on tacrolimus. CsA might be implicated in FA development in adolescent females after LDLT.
Publisher	John Wiley and Sons Inc
Source Title	Pediatric Transplantation
Volume (Issue)	21(6)
Page	e12947
Date of Issued	2017-09-01
Language	English
Handle URL	https://hdl.handle.net/11094/99836
PISSN	13973142
eISSN	13993046
Relation.isVersionOf	DOI (Publisher Version) https://doi.org/10.1111/petr.12947
Access Rights	open access
CopyRight	© 2017 John Wiley & Sons A/S.
oaire:version	Accepted Manuscript
Category	学術雑誌論文 Journal Article

Resource Type	journal article
Local Type	Journal Article
DCTERMS.bibliographicCitation	Pediatric Transplantation. 2017, 21(6), p. e12947
DC.title	Fibroadenoma in adolescent females after living donor liver transplantation
DC.creator	Tanaka, N.
	Ueno, T.
	Takama, Y.
	Yamanaka, H.
	Tazuke, Y.
	Bessho, K.
	Okuyama, H.
DC.publisher	John Wiley and Sons Inc
DC.language' scheme='DCTERMS.RFC1766	English
DCTERMS.issued' scheme='DCTERMS.W3CDTF	2017-09-01
DC.identifier	https://doi.org/10.1111/petr.12947
DC.subject	adolescent female
	cyclosporine
	fibroadenoma
	living donor liver transplantation
DC.description	This is the peer reviewed version of the following article: Tanaka N., Ueno T., Takama Y., et al. Fibroadenoma in adolescent females after living donor liver transplantation. Pediatric Transplantation 21, e12947 (2017), which has been published in final form at https://doi.org/10.1111/petr.12947. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages thereof by third parties from platforms, services and websites other than Wiley Online Library must be prohibited.
DCTERMS.abstract	Breast FA is the most common breast tumor diagnosed in young women. Female renal transplant recipients on CsA have an increased risk of developing FA. However, reports of FA after LDLT have not been described. Our objectives were to determine the incidence of FA, analyze risk factors for FA, and evaluate treatment strategies in adolescent females after LDLT. A total of 18 female patients aged 10-19 years who underwent LDLT and survived at least one year after transplantation were enrolled in our study. The incidence of FA was 11.1%. To determine pre- or post-transplant conditions that are associated with FA after transplantation, the patients were divided into two groups according to the presence or absence of FA: FA group (n=2) and non-FA group (n=16). There were no differences in mean age at LDLT, mean age at breast evaluation, and mean duration between transplantation and breast evaluation between the two groups. However, there was a difference in the immunosuppressive regimen between the two groups. The FA group was maintained on CsA, whereas the non-FA group was maintained on tacrolimus. CsA might be implicated in FA development in adolescent females after LDLT.
DC.rights	© 2017 John Wiley & Sons A/S.
DC.format	99836
citation_title	Fibroadenoma in adolescent females after living donor liver transplantation
citation_author	Tanaka, N.
	Ueno, T.
	Takama, Y.
	Yamanaka, H.
	Tazuke, Y.
	Bessho, K.
	Okuyama, H.
citation_publisher	John Wiley and Sons Inc
citation_language	English
citation_date	2017-09-01
citation_journal_title	Pediatric Transplantation
citation_volume	21
citation_issue	6
citation_firstpage	e12947
citation_doi	https://doi.org/10.1111/petr.12947
citation_public_url	https://hdl.handle.net/11094/99836

Fibroadenoma in adolescent females after living donor liver transplantation

Link to primary information

Item Information

Show details